Case Note & Summary
The dispute arose from notifications and demand notices issued by the respondents for recovery of amounts from the petitioners, alleging sales of a medicinal formulation beyond the ceiling price fixed under the Drugs (Price Control) Order, 1995 (DPCO 1995). The petitioners, M/s. Pharmed Limited and its director, challenged the validity of these notifications, asserting that the NPPA had overstepped its authority and that the ceiling price for their formulation, 'Cartigen Forte Tablets', had never been established. The petitioners contended that the notifications dated 27.09.2007 and 30.01.2009 were inapplicable to their product, which was used for treating osteoarthritis and did not fall under the category of multivitamins or minerals as defined in the DPCO. They argued that the impugned notifications were overly broad and violated the provisions of the DPCO. The respondents, however, maintained that the formulation contained ingredients classified as bulk drugs under the DPCO, justifying the imposition of ceiling prices. The court analyzed the definitions and provisions of the DPCO, concluding that the NPPA acted within its powers and that the petitioners had failed to demonstrate a lack of authority in the NPPA's actions. The court also addressed the petitioners' claims regarding violations of natural justice, finding that the NPPA had provided adequate opportunities for the petitioners to present their case. Ultimately, the court dismissed the writ petition, upholding the validity of the NPPA's notifications and the demand for recovery of overcharged amounts.
Headnote
A) Administrative Law - Delegation of Powers - Validity of NPPA Notifications - Drugs (Price Control) Order, 1995 - The NPPA's issuance of notifications fixing ceiling prices for formulations was challenged on grounds of improper delegation of authority from the Central Government. The court held that the NPPA acted within its delegated powers under the DPCO 1995, thus validating the notifications (Paras 1-2). B) Pharmaceutical Law - Ceiling Price Determination - Overcharging Claims - Drugs (Price Control) Order, 1995 - The petitioners contended that the ceiling price for their formulation was never fixed, and thus, demands for overcharging were unjustified. The court found that the formulation contained ingredients classified under the DPCO, justifying the imposition of ceiling prices and the consequent recovery of overcharged amounts (Paras 3-4). C) Natural Justice - Consideration of Submissions - DPCO 1995 - The petitioners argued that their submissions were not considered adequately in the proceedings. The court determined that the NPPA had provided sufficient opportunity for hearing and considered the petitioners' contentions before issuing demand notices (Paras 14-19).
Issue of Consideration
Whether the notifications issued by the NPPA for fixing ceiling prices for the petitioners' formulation were valid under the DPCO 1995.
Final Decision
The court dismissed the writ petition, upholding the validity of the NPPA's notifications and the demand for recovery of overcharged amounts, finding that the NPPA acted within its powers under the DPCO 1995.
Law Points
- Price control
- ceiling price
- pharmaceutical formulations
- delegation of powers
- natural justice
- overcharging
- DPCO 1995
